GCA
ALKS icon

Genesee Capital Advisors’s Alkermes ALKS Stock Holding History

Genesee Capital Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-51,328
Closed -$1.15M – 81
2022
Q3 		$1.15M Sell
51,328
-749
-1% -$19.5K 0.87% 37
2022
Q2 		$1.55M Buy
+52,077
New +$1.5M 1.08% 25

Other funds holding ALKS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Genesee Capital Advisors's ALKS Position: Q4 2022 in Review

Genesee Capital Advisors sold out of Alkermes (ALKS) in Q4 2022, closing a stake of 51,328 shares — an estimated $1.15M sold.

Genesee Capital Advisors first reported a position in ALKS in Q2 2022 and held it in 2 quarters. The position peaked at $1.55M in Q2 2022. 277 funds tracked by Wall St. Rank hold ALKS as of Q4 2022.

  • Genesee Capital Advisors reported no remaining Alkermes position as of Q4 2022 after selling out during the quarter.
  • Genesee Capital Advisors sold 51,328 Alkermes shares in Q4 2022, an estimated $1.15M.
  • Genesee Capital Advisors first reported a position in Alkermes in Q2 2022 and held it in 2 quarters.
  • Genesee Capital Advisors's Alkermes position peaked at $1.55M in Q2 2022.
  • 277 funds tracked by Wall St. Rank held Alkermes as of Q4 2022.

Based on Genesee Capital Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.